Clinical Trial Update: Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating reduced-intensity hematopoietic stem cell transplantation for DOCK8 deficiency; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dock8 Deficiency

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: DOCK8 Deficiency | Phase 2 | Status: ACTIVE_NOT_RECRUITING